TNF-α and IL-10 levels in tracheobronchial lavage of ventilated preterm infants and subsequent lung function

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 4, 2007, Pages 569-576

  Corso, A L ^a   Pitrez, P M C ^a   Machado, D C ^a   Stein, R T ^a   Jones, M H ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Chronic lung disease; Inflammation; Interleukin 10; Newborn; Prematurity; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

AMNION; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY FLOW; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; INFANT; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MALE; MEMBRANE RUPTURE; MULTIVARIATE ANALYSIS; PREMATURITY; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFLAMMATION; RISK FACTOR; TRACHEOBRONCHIAL TOILET;

EID: 34247278343     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000400016     Document Type: Article

References (38)

1. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001; 160: 457-463.
2. Welty SE. Is oxidant stress in the causal pathway to bronchopulmonary dysplasia? NeoReviews 2000; 1: 6-10.
3. Lyon A. Chronic lung disease of prematurity. The role of intra-uterine infection. Eur J Pediatr 2000; 159: 798-802.
4. McColm JR, Stenson BJ, Biermasz N, McIntosh N. Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 2000; 82: F156-F159.
5. Stark AR. High-frequency oscillatory ventilation to prevent bronchopulmonary dysplasia - are we there yet? N Engl J Med 2002; 347: 682-684.
6. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 181: 773-779.
7. Fitzgerald DA, Mesiano G, Brosseau L, Davis GM. Pulmonary outcome in extremely low birth weight infants. Pediatrics 2000; 105: 1209-1215.
8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
9. Jonsson B, Li YH, Noack G, Brauner A, Tullus K. Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr 2000; 89: 1375-1380.
10. Jonsson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 77: F198-F201.
11. Northway WH Jr. Bronchopulmonary dysplasia: twenly-five years later. Pediatrics 1992; 89: 969-973.
12. Northway WH Jr. An introduction to bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 489-495.
13. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001; 18: 1-9.
14. An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, et al. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 2004; 191: 1649-1654.
15. Bancalari E. Epidemiology and risk factors for the "new" bronchopulmonary dysplasia. NeoReviews 2000; 1: 2-5.
16. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995; 73: F1-F3.
17. McColm JR, McIntosh N. Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease in premature infants. Lancet 1994; 343: 729.
18. Schultz C, Tautz J, Reiss I, Moller JC. Prolonged mechanical ventilation induces pulmonary inflammation in preterm infants. Biol Neonate 2003; 84: 64-66.
19. Deng H, Mason SN, Auten RL Jr. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000; 162: 2316-2323.
20. Kotecha S. Cytokines in chronic lung disease of prematurity. Eur J Pediatr 1996; 155 (Suppl 2): S14-S17.
21. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995; 72: F90-F96.
22. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975.
23. Dudley DJ, Hunter C, Mitchell MD, Varner MW. Amniotic fluid interleukin-10 (IL-10) concentrations during pregnancy and with labor. J Reprod Immunol 1997; 33: 147-156.
24. Ozdemir A, Brown MA, Morgan WJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol 1997; 23: 292-306.
25. de Blic J, Midulia F, Barbato A, Clement A, Dab I, Eber E, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000; 15: 217-231.
26. Feher A, Castile R, Kisling J, Angelicchio C, Filbrun D, Flucke R, et al. Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes. J Appl Physiol 1996; 80: 2019-2025.
27. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, et al. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000; 161: 353-359.
28. Huang HC, Yang MY, Huang CB, Yang KD. Profiles of inflammatory cytokines in bronchoalveolar lavage fluid from premature infants with respiratory distress disease. J Microbiol Immunol Infect 2000; 33: 19-24.
29. Oei J, Lui K, Wang H, Henry R. Decreased interleukin-10 in tracheal aspirates from preterm infants developing chronic lung disease. Acta Paediatr 2002; 91: 1194-1199.
30. Beresford MW, Shaw NJ. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 2002; 52: 973-978.
31. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160: 1333-1346.
32. Naik AS, Kallapur SG, Bachurski CJ, Jobe AH, Michna J, Kramer BW, et al. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 2001; 164: 494-498.
33. Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996; 155: 112-116.
34. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825-830.
35. Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 9-17.
36. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171-176.
37. Murch SH, MacDonald TT, Wood CB, Costeloe KL. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992; 47: 44-47.
38. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994; 36: 244-252.